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The manipulation of a speciﬁc gene in NOD mice, the
best animal model for insulin-dependent diabetes mellitus
(IDDM), must allow for the precise characterization of the
functionalinvolvementofitsencodedmoleculeinthepatho-
genesis of the disease. Although this has been attempted by
the cross-breeding of NOD mice with many gene knockout
mice originally created on the 129 or C57BL/6 strain back-
ground,theinterpretationoftheresultingphenotype(s)has
often been confusing due to the possibility of a known or
unknown disease susceptibility locus (e.g., Idd locus) coseg-
regating with the targeted gene from the diabetes-resistant
strain. Therefore, it is important to generate mutant mice
on a pure NOD background by using NOD-derived embry-
onic stem (ES) cells. By using the NOD ES cell line estab-
lishedbyNagafuchiandcolleaguesin1999(FEBSLett.,455,
101–104), the authors reexamined various conditions in the
context of cell culture, DNA transfection, and blastocyst in-
jection, and achieved a markedly improved transmission
efﬁciency of these NOD ES cells into the mouse germ line.
These modiﬁcations will enable gene targeting on a “pure”
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Insulin-dependent diabetes mellitus (IDDM) is an autoim-
mune disease that is characterized by the speciﬁc destruction
of the insulin-producing β-cells of the Langerhans islets within
the pancreas. An important animal model for IDDM is the
nonobese diabetic (NOD) mouse. Because humans and the
NOD mouse share most of the fundamental characteristics of
IDDM, the NOD mouse has been extensively studied in order
to better understand the etiology and pathogenesis of the dis-
ease [1–4]. To date, more than 20 insulin-dependent diabetes
(Idd) genes that inﬂuence the disease have been mapped in
the NOD mouse [5–11]. These loci correspond to allelic poly-
morphisms between NOD mice and diabetes-resistant strains,
such as C57BL/6 (B6). Idd1 and Idd16 are located within the
major histocompatibility complex (MHC), and Idd1 probably
corresponds to allelic variations in the I-A molecule [6, 10].
In addition to known MHC contributions, variations in many
non-MHC molecules, which are speciﬁc to the NOD strain,
inﬂuence the initiation and/or the progression of IDDM, both
directly and indirectly.
To address how any of these molecules is physiologically
involved in the pathogenesis of IDDM in NOD mice, the best
method is to diminish the function of the speciﬁc gene in ques-
tion. To this end, many null-mutant mice for various genes that
had originally been generated in embryonic stem (ES) cells
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derived from the 129 (Sv or Ola) or B6 strains via homologous
recombination were backcrossed to NOD mice, and disease
progression was assessed in the resulting mice [12]. However,
itisdifﬁculttoapplythisstrategywhenthetargetgeneistightly
linked to any of the known Idd loci, as the Idd loci from the
diabetes-resistant strain (129 or B6) will cosegregate with the
targeted allele. This makes discrimination between the contri-
butions from the gene mutation versus the linked Idd resistance
allele a difﬁcult task. Even when the target gene is not mapped
to known Idd loci, there may nevertheless be unknown Idds
closely linked to the target gene, thus complicating the inter-
pretation of the phenotype(s) of the backcrossed mice. There-
fore, it is very desirable to perform gene manipulation using
NOD-derived ES cells. After extensive trials by numerous re-
searchers, Nagafuchi and colleagues successfully established a
NOD-derived ES cell line [13]. However, this original report
showed very low germ line transmission efﬁciency of these
NODEScells[13].Inaddition,thesecellsappearedtobemore
susceptible to differentiation than other ES cell lines (such as
E14.1cellsderivedfromthe129/Olamousestrain),thusrequir-
ing much higher concentrations of leukemia-inhibitory factor
(LIF) in the culture medium. Probably due to these difﬁculties,
there has been no evidence of successful gene targeting in pure
NOD ES cells, although germ line competent ES cells from
[NOD × 129/Ola]F1 mice have been produced [14]. We, how-
ever, have achieved markedly improved germ line transmission
efﬁciency of these NOD ES cells by reexamining conditions
for cell culture as well as blastocyst injection of these cells. In
this report, we will discuss the improved procedures that result
in a high germ line transmission efﬁciency of NOD ES cells.
MATERIALS AND METHODS
Mice
Mice were bred and maintained in speciﬁc pathogen–free
(SPF) animal facilities at the University of Texas Southwestern
Medical Center at Dallas, and the Basel Institute for Immunol-
ogy (Basel, Switzerland). Vasectomized male CD-1 mice were
purchased from the Jackson Laboratory.
NOD ES Cells
The NOD/Shi-derived ES cells that had been established by
Nagafuchi and colleagues [13] were used in this study. Various
lots of cells between passages 10 and 15 were used.
Cell Culture Materials
TheculturemediumwaspreparedbasedonDulbecco’smod-
iﬁed Eagle’s medium (DMEM) (high glucose; 4.5 mg/mL)
(Gibco-BRL). Multiple lots of fetal calf serum (FCS) were
purchased from three different suppliers (Gibco-BRL, Fis-
cher Scientiﬁc and HyClone). FCS was heat-inactivated before
use. LIF was purchased from Chemicon International. Antibi-
otics (penicillin-streptomycin, gentamycin), β-mercaptethanol
(2-ME), and G418 (geneticin) were purchased from Gibco-
BRL.
Feeder Cells
For feeder layers, mouse embryonic ﬁbroblast (MEF) cells
were prepared from embryonic days (E) E12.5 to E13.5 mouse
embryos of various strains (e.g., C57BL/6, NOD, 129/Ola,
[129/Ola×B6]F1,BALB/c)asdescribedelsewhere[15].MEF
cellswerealsogeneratedfrommicefroma129/Ola×B6back-
ground containing the neomycin-resistance gene (neor), by us-
ing AIM+/− mice [16]. AIM is an apoptosis inhibitory factor,
which is restrictedly produced by macrophages [16]. AIM+/−
micerevealednophenotype.Feedercellswereirradiated(2000
rad by 137Cs source) before use.
Electroporation and G418 Screening
Electroporation of DNA into ES cells was performed as
described previously [16]. Brieﬂy, 107 ES cells suspended in
0.5 mL of ES culture medium were electroporated with 15 µg
of XhoI-linearized pMC1-neo-polyA in a 0.4-cm-distance cell
electroporation cuvette (BioRad) under various conditions, us-
ing Gene Pulser II (BioRad). After electroporation, cells were
selected by 150 µg/mL of G418 (Geneticin, Gibco-BRL) for
7 to 10 days. Surviving colonies were isolated and screened for
DNA integration by Southern blotting.
Southern Blotting
A total of 15 µg of genomic DNA from ES cells or mouse
tailswasdigestedbyEcoRIandBamHI,separatedonanagarose
gel,denatured,andthenblottedonanylonmembrane.Theblot-
tedDNAwashybridizedwitha 32P-labeledEcoRI-BamHI neor
gene DNA fragment from pMC1-neor-PolyA (Stratagene).
Blastocyst Injection
E3.5 embryos (at the blastocyst stage) were isolated from
pregnantNODorB6femalemiceasdescribed[15].Eightto12
EScellsweremicroinjectedintoablastocyst.Injectedembryos
were transplanted into the uteri of pseudopregnant CD-1 foster
females (3.5 days after mating with vasectomized male CD-1
mice).
RESULTS
The efﬁciency of the contribution of ES cells to chimera
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(1)thepluripotentphenotypeoftheEScells,whichiscritically
inﬂuencedbythecellcultureconditions;and(2)acombination
of the genetic backgrounds of the ES cells and the recipient
blastocysts [17, 18]. We readdressed these 2 issues, in order to
obtain efﬁcient transmission of NOD ES cells into the mouse
germ line.
NOD ES Cells Requirement for Feeder Cells
Is Not Strain Speciﬁc
We ﬁrst assessed whether NOD ES cells require a speciﬁc
feeder layer cell type, by culturing the NOD ES cells on either
(1) a gelatinized cell culture dish without feeder cells; (2) B6 ×
129/sv–derivedmouseMEFcells;(3)NOD-derivedMEFcells;
or (4) BALB/c-derived MEF cells (which were used during the
original establishment of the NOD ES cells [13]). Before use,
MEFcellswereirradiated(2000rad,by 137Cssource)toprevent
theirproliferation.Atotalof5×103 NODEScellswereplated
ona6-cm-diametercellculturedishpreplatedwitheitheroneof
the different types of feeder cells or no feeder cells. Cells were
cultured in a complete culture media of DMEM (high-glucose;
4.5 mg/mL), supplemented with 20% of FCS, 104 U/mL of
LIF, 1 × gentamicin, and 2-ME. During the culture period,
when the cells in the dish were approximately 80% conﬂuent,
they underwent a passage from 1 to 4 dishes. After 3 passages,
differentiation of the cells was assessed by morphology, i.e.,
thesharp-edgeoftheEScoloniesandtheindistinguishablecell
junctionwithinacolony.Intheabsenceoffeedercells,theNOD
ES cells underwent complete differentiation during the culture
(Figure 1). Most of the cells (colonies) had already begun dif-
ferentiation 1 to 2 days after the culture started. In contrast,
the other 3 types of feeder cells almost completely supported
the undifferentiated status of the NOD ES cells. Therefore, al-
thoughtheNODEScellsareentirelydependentonthepresence
of feeder layer cells, no strain speciﬁcity for MEF feeder cells
was found.
NOD ES Cells Are Sensitive to FCS
Batch Variation
ES cells are generally very sensitive to FCS in the context of
(1) toxicity, which causes cell death and/or growth prevention,
and(2)theinductionofdifferentiationofthesecells.According
to the observation that NOD ES cells are more susceptible to
differentiation than other ES cells, it was critical to select lots
of FCS that did not promote this terminal differentiation. To
assessthis,wetested10lotsofFCSnewlypurchasedfromthree
differentsuppliers(lots1to4,5to7,and8to10werepurchased
fromrespectivesuppliers).WeculturedNODES,E14.1ES,and
D3 ES (derived from the 129/Sv strain) cells in the presence
of each lot of FCS (heat-inactivated) at 30% volume/volume
FIGURE 1
Requirement of feeder cells for NOD ES cells. A total of 5 ×
103 NOD ES cells were plated on a 6-cm diameter dish with
(1) no feeder cells (gelatinized); (2) [B6 × 129/Sv]F1-derived
MEF cells; (3) NOD-derived MEF cells; or (4)
BALB/c-derived MEF cells. MEF cells were irradiated before
use (2000 rad by a 137Cs source). Cells were cultured in the
presence of 20% heat-inactivated FCS and 104 U/mL of LIF.
After 3 passages, the differentiation status was
morphologically assessed. The proportion of differentiated
colonies is presented. Without feeder cells, most of the cells
differentiated within the ﬁrst 2 days of culture (*).
(v/v). LIF was supplemented at 104 U/mL concentration. We
plated 103 cells on a 6-cm-diameter cell culture dish, preplated
with irradiated MEF cells derived from [129 × B6]F1embryos,
and continued the culture for 5 days observing (1) the number
of colonies and (2) the differentiation status of the ES cells. As
a control, we also cultured E14.1 ES cells with the FCS that is
used for E14.1 cells in our laboratory. We evaluated the results
with respect to the 2 issues described above for each lot of FCS
in comparison with the standard FCS. Interestingly, the overall
results were very different for the NOD ES and the other two
129-derived ES cells. As shown in Table 1, three (2, 7, 8) out
of the 10 lots did not support NOD ES cell growth at all: most
of the cells were dead within 48 hours after the culture started.
Five(1,3,4,6,10)outof10werenottoxicforthecells,butdid
not preserve the undifferentiated status of the NOD ES cells:
coloniesdidgrowbutmostofthecellsdifferentiated.Theother
twolots(5,9)satisﬁedbothparameters.Inthepresenceofeither
ofthese2FCSlots,theoverallsizeoftheNODEScellcolonies
was comparable to those of E14.1 ES cells cultured with the
standard FCS, suggesting those two FCS lots did not prevent
the growth of NOD ES cells. Interestingly, out of the 8 lots
that were not appropriate for the NOD ES cells, 6 of these lots
of FCS did support both the growth and the undifferentiated
status of E14.1 and D3 ES cells. In fact, to our surprise, lot
2, which entirely killed the NOD ES cells, provided the best
results for the E14.1 and D3 ES cells. These results indicate
that the NOD ES cells appear to be more sensitive to FCS than222 S. ARAI ET AL.
TABLE 1
Comparison of various lots of FCS
FCS lot no.
1 2 3 4 5 6 7 8 9 10 Standard
Colony-forming efﬁciency (%)
NOD 45 0 25 60 75 45 <10 <10 70 35 N.D.
E14.1 85 >95 80 80 75 50 85 55 >95 90 100
D3 >95 >95 75 85 65 60 >95 60 90 >95 N.D.
Differentiation (− ∼ +++)
NOD +++ N.D. +++ ++ − ∼ ± +++ N.D. N.D. −+ + N.D.
E14.1 − − −− ∼ ±−± − +− − −− −
D3 − − −∼± −∼± − + −∼± ± − + − − N.D.
Note. Ten lots of FCS were purchased from various agents. A total of 103 ES cells were plated on a dish with irradiated feeder layers in the
presence of each lot of heat-inactivated FCS at 30% concentration supplemented with 104 U/mL of LIF for 5 days. E14.1 cells were also cultured
with a standard FCS. The colony-forming efﬁciency represents the number of colonies in comparison of that of E14.1 cells cultured with the
standard FCS. N.D., not determined.
129-derivedcells,andhaveasomewhatunique“taste”forFCS.
Thus,NODEScellsrequirespeciﬁclotsforthemaintenanceof
their growth and pluripotent character. Therefore, investigators
need to rigorously test multiple batches of FCS to identify an
appropriate lot for NOD ES cell culture.
NOD ES Cells Require a Higher Concentration
of LIF
Most ES cell lines require approximately 5 × 102 to 1 ×
103 U/mLofLIFtomaintaintheirpluripotentphenotype.Inthe
initial report, Nagafuchi and colleagues established the NOD
EScelllineusing104 U/mLofLIF,andthusrecommendedthis
concentration for the culture of these ES cells [13]. However,
according to our experience with other ES cell lines, too high
of a LIF concentration sometimes affects the character of the
cells, resulting in a low contribution of the ES cells to the germ
cellsandconsequentgermlinetransmission(T.M.,unpublished
result). Therefore, to determine the minimum concentration re-
quired for NOD ES cells, we cultured the NOD ES cells under
different concentrations of LIF, and evaluated their differenti-
ation status by judging the appearance of the colonies. In the
presence of 103 U/mL, which is sufﬁcient for most other lines,
the NOD ES cells differentiated rapidly, suggesting that NOD
ES cells do require higher concentrations of LIF. When 3 ×
103 U/mL of LIF was used, the undifferentiated status of the
NOD ES cells was preserved, and there was no difference in
the ability of this concentration to support the growth of the ES
cells as compared to 104 U/mL of LIF during standard culture
with occasional passages (Figure 2A). Interestingly, however,
whenEScellswereculturedfor10dayswithout passages,asin
FIGURE 2
Requirement of a high concentration of LIF for NOD ES cells.
A total of 2 × 103 of NOD ES cells were plated on a 10-cm
dish with irradiated feeder cells in the presence of various
concentrations of LIF. (A) Standard culture: After 3 passages,
the proportion of differentiated colonies in a dish was assessed
by morphology. In the presence of 3 × 103 U/mL LIF most of
the colonies were maintained as undifferentiated.
(B) Long-term culture: Cells were cultured for 10 days without
passage. Culture medium was changed everyday. A minimum
of 104 U/mL of LIF supported the undifferentiated status of
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theselectionofcoloniesbysomeselectivereagent(e.g.,G418),
which is required for gene-targeting experiments, 104 U/mL of
LIFwasrequiredtokeepthecellsundifferentiated(Figure2B).
Thus,3×103 U/mLofLIFappearstobesufﬁcientforstandard
culture of NOD ES cells, though 104 U/mL is necessary during
selection of gene-transfected cells.
Electroporation Conditions for NOD ES Cells
In our laboratory, we normally introduce DNA into ES cells
via electroporation (EP), which is known to be the best trans-
fection strategy for ES cells [19]. As described in our previous
reports, we use speciﬁc conditions, 400 V, 125 µF, in a 0.4-cm-
distance cuvette [16]. When applied to E14.1 ES cells, these
conditions usually result in 15% to30% of the ES cells surviv-
ing after EP, with 0.02% to 0.1% of the ES cells having DNA
integration into their genomes (1000 to 5000 stably transfected
colonies after EP of 5 × 106 ES cells). However, when the
NOD ES cells underwent EP under these conditions, most of
the cells were dead after EP, and no stable transfectant was
obtained, suggesting that NOD ES cells are more sensitive to
the EP procedure than other ES cell lines (Figure 3A). This
is reminiscent of the fragility of fertilized NOD eggs, which
FIGURE 3
Electroporation conditions for NOD ES cells. A total of 5 ×
106 of E14.1 (white box) or NOD ES (black box) cells were
electroporated under the conditions of 400 V, 125 µF(A)o r
300 V, 100 µF(B), with 15 µgo fXhoI-linearized
pMC1-neor-polyA DNA, and plated on 5 × 10-cm dishes with
irradiated feeder cells. Twenty-four hours after the
electroporation, the number of surviving colonies was counted
(left). After another 24 hours, 150 µg/mL of G418 was added
to the culture medium for selecting the stable transfectant cells.
Cells were selected for 10 days, and thereafter, the numbers of
surviving colonies were counted (right).
is apparent when we generate transgenic NOD mice via di-
rect microinjection of a DNA fragment into NOD fertilized
eggs [20, 21]. NOD embryos are markedly more susceptible
to death by the microinjection procedure than embryos from
other strains such as B6 or [B6 × DBA2]F1 (BDF1), which
results in difﬁculties when attempting to generate transgenic
mice on a pure NOD background (T. Miyazaki, unpublished
observation). After evaluating various sets of conditions, we
identiﬁed speciﬁc conditions (300 V, 100 µF) that least dam-
agedtheNODEScellsasascertainedbythenumberofcolonies
that appeared after EP (30% to 40% of that seen for E14 ES
cells;Figure 3B,left).WhentheNODEScellswereelectropo-
rated with a neomycin-resistant gene (neor; pMC1-neo-polyA,
Stratagene)undertheseconditions,morethan300coloniessur-
vivedafterselectionwith150µg/mLofG418for10daysinthe
presence of 104 U/ml of LIF. The overall number of surviving
colonies was approximately 30% to 40% of that observed for
E14.1 ES cells undergoing the same transfection/selection pro-
cess (Figure 3B, right). Note that the stable DNA introduction
into E14.1 ES cells in this experiment was less efﬁcient due to
the milder EP conditions as compared to those normally used
forthesecells(400V,125µF).OfthesesurvivingNODEScell
colonies,20werepickedandscreenedforneor geneintegration
by polymerase chain reaction (PCR). All 20 clones harbored
the integrated neor gene. Eighteen out of the 20 clones main-
tained undifferentiated morphologies after several passages in
the presence of 3×104 U/mL of LIF. Two of these were further
expanded, and used in the following experiments to produce
chimeric mice.
Efﬁcient Chimeric Contribution and Germ Line
Transmission of the NOD ES Cells
The initial report describing NOD ES cells showed a very
low germ line transmission efﬁciency of these cells after injec-
tion into blastocysts from B6 mice. Although highly chimeric
(>80%) male mice were obtained, the efﬁciency of germ line
transmission was a maximum of ∼1% (1 out of 97 offspring
from the most chimeric male). It is well known that the combi-
nation of the genetic background of the ES cells and the recip-
ient embryos (blastocysts) is one of the important parameters
thatcriticallydeﬁnestheefﬁciencyofchimericcontributionand
germlinetransmissionofEScells[17,18].Therefore,wewon-
dered whether injection of the NOD ES cells into blastocysts
from different strains of mice might result in improved germ
linetransmissionefﬁciency.Conceivably,thebeststrainforpro-
viding blastocysts for NOD ES cells might be the NOD strain
itself. To test this hypothesis, we injected neor-NOD ES cells
(see previous section) into blastocysts from either B6 or NOD
mice. Because chimeric contribution of the injected NOD ES
cellscannotbeevaluatedinNODrecipientsbycoatcolor(NOD224 S. ARAI ET AL.
FIGURE 4
Efﬁcient germ line transmission of NOD ES cells. The neorgene–transfected NOD ES cells were microinjected into blastocysts
derived from B6 or NOD females. (A) Two highly chimeric (as judged by coat color) male mice from B6 blastocysts, and 3
randomly selected male mice from NOD blastocysts were sacriﬁced, and their testis DNA was analyzed for the neor gene by
Southern blotting. The apparently highly chimeric mice from B6 blastocysts revealed a low contribution of injected NOD ES
cells in the testis (germ cells) (left), whereas all of the 3 NOD chimeras showed a markedly higher contribution of injected cells
(right). N.D., not determined. (B) The remainder of the chimeric male mice, 10 males for each strain, were bred with B6 females,
and their progeny was tested for the presence of the neor gene by analyzing genomic DNA isolated from tails by PCR. Because
the neor gene should be integrated in a heterozygous fashion, the neor-positive proportion was doubled to represent the
transmission efﬁciency of NOD ES cells into the germ line. G. L.T., germ line transmission efﬁciency.
EScellsgiverisetothesamecoatcolorastheNODrecipients),
we randomly sacriﬁced 3 male mice selected from 16 NOD re-
cipient male chimeras, and tested the contribution of the NOD
ES cells to the germ cells by Southern blot analysis for the neor
gene, using genomic DNA from the testis of these mice. All 3
NODchimeras(2oftheminparticular)revealedhighercontent
oftheneor geneinthetestisthanthehighlychimeric(>80%,as
judgedbycoatcolor)B6recipientmice(Figure4A).Thisresult
demonstrates a potentially higher contribution of the NOD ES
cells to the germ cells in NOD recipient chimeric mice than in
B6 chimeric mice. The remaining male NOD and B6 chimeric
mice (10 mice for each strain) were bred with B6 females. The
germ line transmission of the ES cells in each chimeric mouse
was assessed in their progeny by PCR for the neor gene us-
ing tail genomic DNA (Figure 4B). Because the ES cells were
heterozygous for the neor gene, the results should be 50% of
the real germ line transmission efﬁciency (shown as G.L.T. in
Figure 4B). Germ line transmission of NOD ES cells from the
B6recipientchimerasintotheirprogenywasverylow,conﬁrm-
ing the results by Nagafuchi and colleagues [13]. In contrast,
analysis of progeny of NOD recipient chimeras revealed a far
higher efﬁciency of germ line transmission, clearly indicating
that using NOD blastocysts as recipients markedly improved
the germ line transmission efﬁciency of NOD ES cells.
DISCUSSION
In this report, we reevaluated cell-culture and blastocyst-
injection conditions for the NOD ES cells that had been
established by Nagafuchi and colleagues, and achieved
markedly improved transmission efﬁciency of these cells into
the mouse germ line.
Perhaps the most important improvement is the use of
NOD blastocysts, instead of B6 blastocysts, for the creation
of chimeric mice. The exact reason why the particular strain
combination of ES cells and blastocysts critically deﬁnes the
efﬁcacy of chimeric contribution and germ line transmission
of ES cells is still unclear [17, 18]. It is plausible that the
stem cells from the inner cell mass of the blastocysts of cer-
tain strains may grow more rapidly than the injected ES cells,
resulting in a low contribution of the ES cells to a variety of
tissues. Indeed, even in vitro, the NOD ES cells appeared to
grow more slowly than E14.1 ES cells, and hence required a
longer period between cell passages (data not shown). How-
ever, it is intriguing that the contribution of the NOD ES
cells to the coat color phenotype failed to predict germ line
contribution when injected into B6 blastocysts: even highly
chimeric mice in terms of coat color exhibited an extremely
low contribution of the NOD ES cells to the germ cells. The
level of contribution of the injected ES cells might be deﬁnedEFFICIENT TRANSMISSION OF NOD-DERIVED STEM CELLS 225
differently in each organ, perhaps after the cell fate is com-
mitted, via differences in cell growth rate and possibly other
unknown parameters.
The disadvantage of using blastocysts derived from the
same mouse strain as the ES cells is the difﬁculty in judg-
ing chimerism by coat color (which, however, does not always
reliably represent the contribution of the ES cells to the germ
cells, as discussed above). This problem could be overcome
by employing certain congenic NOD mouse stocks that are
nonalbino. For instance, a NOD congenic stock possessing a
wild-type tyrosinase allele and thus developing the agouti coat
color (available from the Jackson Laboratory) could be a use-
ful strain to serve as a source of blastocysts for the NOD ES
cells. In the resulting chimeric mice, contribution of the NOD
ES cells could be easily estimated by judging the albino:agouti
ratio of the coat color.
It may be noteworthy that NOD blastocysts were markedly
more fragile than blastocysts from other strains (e.g., B6, CD-1
and BDF1), which frequently caused mechanical destruction of
the NOD blastocysts during microinjection. Because of this, a
larger number of NOD blastocysts must be injected to obtain
sufﬁcient numbers of chimeric mice. The genetic basis for this
fragility is unknown. If these gene(s) are identiﬁed, however,
the use of NOD strains congenic for the gene(s) could also
strikinglyimprovetheefﬁcacyofcreatingNODEScell–derived
mice.
Recently, Brook and colleagues successfully established an
EScelllinefromthe[NOD×129/Ola]F1mouse,whichdemon-
strated good germ line transmission efﬁciency [14]. Gene tar-
geting of the NOD allele in these F1 ES cells will deﬁnitively
eliminatethesegregationofnon-NODIdd locicloselylinkedto
thetargetedgene.However,theresultingmicefromthetargeted
F1 ES cells still require multiple backcrosses to NOD mice to
eliminate known and unknown Idd disease resistance loci de-
rived from the 129 chromosomes. This may be a disadvantage
of these F1 ES cells when compared to pure NOD ES cells.
Inthisstudy,wedeterminedthedifferentiationofEScellsby
morphology. We believe that morphology-based evaluation is
highly reliable, based on the clearly different morphology seen
between differentiated and undifferentiated ES cells. Indeed,
NOD ES cells satisfying the morphological criteria for undif-
ferentiated status [15] provided high germ line transmission ef-
ﬁciency under appropriate experimental conditions. However,
a more rigorous method for judging the differentiation of ES
cells (e.g., via measurement of such embryonic markers as Oct
4 and alkaline phosphatases) will be helpful to establish ﬁner
conditions for NOD ES culture [22].
Our improved conditions have resulted in a markedly in-
creasedtransmissionefﬁciencyofNODEScellsintothemouse
germ line and hence will open avenues for directly addressing
the precise involvement of various genes in the pathogenesis
of IDDM through the creation of gene-modiﬁed “pure” NOD
mice.
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